The upcoming RDD Europe 2025 conference in Estoril, Portugal will mark the 20th anniversary of the … [Read More...] about RDD Europe 2025 preview
RDD Europe 2025 preview
DDL 2024 in review
DDL 2024 drew the largest crowd ever in the 35-year history of the Drug Delivery to the Lung (DDL), … [Read More...] about DDL 2024 in review
DDL 2024 to celebrate 35 years as a leading OINDP conference
The annual Drug Delivery to the Lungs (DDL) conference will mark its 35th anniversary during this … [Read More...] about DDL 2024 to celebrate 35 years as a leading OINDP conference
Latest news
Rein Therapeutics initiates Phase 2 trial of its LTI-03 caveolin-1-related peptide DPI in IPF patients
Rein Therapeutics (formerly Aileron Therapeutics) has announced the initiation of the Phase 2 RENEW trial of LTI-03, an inhaled dry powder caveolin-1 scaffolding domain peptide. The company had announced plans for the study in January 2025 and recently said that it had received two new patents … [Read More...] about Rein Therapeutics initiates Phase 2 trial of its LTI-03 caveolin-1-related peptide DPI in IPF patients
UK MHRA approves AstraZeneca’s reformulated Trixeo (Breztri) Aerosphere MDI with HFO-1234ze as the propellant
AstraZeneca announced the that the UK Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the company's marketing application for a reformulated Trixeo (Breztri) Aerosphere budesonide / glycopyrronium / formoterol fumarate that uses Honeywell's Solstice Air HFO-1234ze as a … [Read More...] about UK MHRA approves AstraZeneca’s reformulated Trixeo (Breztri) Aerosphere MDI with HFO-1234ze as the propellant
Aptar CSP expands capacity for clinical packaging of DPI capsules
Aptar CSP Technologies has announced an expansion of its cGMP manufacturing capacity for clinical packaging of dry powder inhalation capsules using the company's Activ-Blister technology. Aptar CSP cited growing demand for the technology for both oral dose and DPI capsules as the reason for … [Read More...] about Aptar CSP expands capacity for clinical packaging of DPI capsules
3P Innovation launches new filling system for generic Diskus and Ellipta DPI products
3P innovation has announced that it is now offering new filling technology in its custom-built DPI filling systems that is based on equipment originally patented by GSK for high-speed filling of Diskus dry powder inhalers. The company notes that its founder, Tom Bailey, led development of filling … [Read More...] about 3P Innovation launches new filling system for generic Diskus and Ellipta DPI products
LTR Pharma announces agreement with SDS for development of nasal spray for difficulty in swallowing
LTR Pharma announced a development agreement with Strategic Drug Solutions, Inc. for development of a nasal spray for the treatment of esophageal motility disorders (difficulty in swallowing). The Australian company says that the product will be called Oroflow but did not provide any additional … [Read More...] about LTR Pharma announces agreement with SDS for development of nasal spray for difficulty in swallowing
Other recent news
- Intertek announces expansion of its Melbourn, UK lab to add space for inhaled biologics testing
- Ethris gets €10 million EU4Health grant for studies of ETH47 inhaled/nasal antiviral
- AstraZeneca says two Phase 3 trials of Breztri Aerosphere MDI in uncontrolled asthma met their primary endpoints
- FDA approves Ritedose’s ANDA for formoterol fumarate inhalation solution
- FDA approves Satsuma’s Atzumi intranasal dry powder DHE for the treatment of migraine